Overview
Dimethylglyoxime (DMG) is a high-affinity, nickel-specific chelator — two DMG molecules coordinate one Ni²⁺ ion to form a characteristic red complex (Tschugaeff reaction). Unlike broad-spectrum chelation agents (EDTA, DMSA) that bind multiple divalent cations indiscriminately, DMG is selective for nickel, making it a precision tool for disabling nickel-dependent virulence without stripping essential metals like zinc, iron, or manganese.
This selectivity is a paradigm shift: chelation therapy is not inherently non-selective. Selective chelators exist, and DMG is the proof of concept.
Anti-Pathogen Activity — The Landmark Finding
The Benoit et al. (2019) study demonstrated that oral DMG is effective against multi-drug resistant (MDR) WHO priority pathogens by targeting their nickel-dependent virulence enzymes [1]:
In Vitro
- Growth inhibition: DMG is bacteriostatic against MDR klebsiella pneumoniae (NDM-1+, carbapenem-resistant) and MDR salmonella Typhimurium at 5–10 mM.
- Hydrogenase abolished: NiFe-hydrogenase activity in Salmonella completely eliminated at 10 mM DMG. Adding NiCl₂ restored activity, confirming the mechanism is nickel sequestration.
- Urease abolished: urease activity in Klebsiella completely eliminated at 5 mM DMG. Since urease-negative K. pneumoniae mutants cannot colonize the intestine, this predicts in vivo efficacy.
In Vivo
- Mouse typhoid model: Oral DMG reduced S. Typhimurium mortality from 100% to 50% (9-day treatment). Organ colonization (liver, spleen) was 10-fold lower in treated mice (P < 0.01).
- Wax moth larvae: DMG pre-treatment led to 40% survival (MDR K. pneumoniae) and 60% survival (MDR S. Typhimurium) vs. 100% mortality without DMG.
- Non-toxic: Oral DMG at therapeutic doses showed zero toxicity symptoms in mice over 6 days. NMR confirmed DMG reaches the liver after oral administration — orally bioavailable.
- Far safer than EDTA: EDTA LD₅₀ ~400 mg/kg; disulfiram LD₅₀ ~200 µg/mouse. DMG showed no toxicity at comparable or higher doses.
WHO Priority Pathogen Coverage
Among the 12 WHO critical MDR pathogens needing new antibiotics most urgently:
- 10 are urease-positive
- 6 are hydrogenase-positive
- 4 have both (hydrogenase + urease)
- 8 have nickel-dependent glyoxalase I
DMG-mediated nickel chelation could be effective against the majority of the world's most dangerous antibiotic-resistant pathogens [1].
Why This Matters for WikiBiome
This paper is the in vivo proof that Karen's Brain Primitive 4 (Metal Dependencies as Achilles' Heels) works as a therapeutic strategy:
- Pathogens cannot evolve around nickel dependency. Antibiotic resistance is encoded on plasmids and can be transferred horizontally. Nickel dependency is encoded in the organism's core metabolism — hydrogenase and urease are essential metalloenzymes, not accessory resistance genes. You can evolve around penicillin; you cannot evolve around needing nickel.
- Selective chelation preserves the commensal microbiome. Most gut commensals (Bacteroidetes, Firmicutes SCFA producers) are not nickel-dependent. By targeting nickel specifically, DMG weakens pathobionts while leaving the protective microbiome intact — the opposite of broad-spectrum antibiotics.
- This approach complements, not replaces, existing therapies. DMG weakens the pathogen's colonization machinery; the host immune system or a co-administered antibiotic finishes the job. DMG could rescue antibiotics that have lost efficacy against MDR strains.
Alzheimer's Application
Separately, DMG has been tested against nickel-induced amyloid-beta aggregation — targeted nickel removal reduces pathological protein misfolding without stripping essential metals [2]. This connects the anti-pathogen and neurodegeneration applications through the same selectivity mechanism.
Nickel Contact Allergy
DMG is also the standard dermatological spot-test reagent for detecting nickel on surfaces (jewelry, implants, tools) in nickel allergy management [3].
Cross-References
- nickel — the target metal
- salmonella — hydrogenase disabled by DMG; in vivo efficacy
- klebsiella — urease disabled by DMG
- antimicrobial resistance — DMG effective where antibiotics fail
- metal chelation therapy — selective vs. non-selective chelation
- nutritional immunity — DMG extends host metal restriction pharmacologically
- microbial metallomics — the framework predicting this intervention
- urease — Ni-dependent enzyme disabled by DMG
- nife hydrogenase — Ni-dependent enzyme disabled by DMG
- amyloid beta — nickel-dependent aggregation reduced by DMG
- curli — Enterobacteriaceae amyloid connection
- competitive exclusion — DMG weakens pathobionts, enabling commensal recovery